Global Vaccine Adjuvants Market Growth 2020-2025
According to this study, over the next five years the Vaccine Adjuvants market will register a 10.6%% CAGR in terms of revenue, the global market size will reach $ 1004 million by 2025, from $ 671.5 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Vaccine Adjuvants business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Adjuvants market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Vaccine Adjuvants, covering the supply chain analysis, impact assessment to the Vaccine Adjuvants market size growth rate in several scenarios, and the measures to be undertaken by Vaccine Adjuvants companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral
Subcutaneous
Intramuscular
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
SEPPIC
GSK
SDA BIO
SPI Pharma
Phibro Animal Health Corporation
Croda International Plc
Zhuoyue
Tj Kaiwei
Aphios
Novavax
Avanti Polar Lipids
Aphios
CSL Limited
SPI Pharma
SEPPIC
Novavax
Brenntag Biosector
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Vaccine Adjuvants consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Vaccine Adjuvants market by identifying its various subsegments.
Focuses on the key global Vaccine Adjuvants manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vaccine Adjuvants with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Vaccine Adjuvants submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Adjuvants Consumption 2015-2025
2.1.2 Vaccine Adjuvants Consumption CAGR by Region
2.2 Vaccine Adjuvants Segment by Type
2.2.1 Oral
2.2.2 Subcutaneous
2.2.3 Intramuscular
2.2.4 Others
2.3 Vaccine Adjuvants Consumption by Type
2.3.1 Global Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
2.3.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2015-2020)
2.3.3 Global Vaccine Adjuvants Sale Price by Type (2015-2020)
2.4 Vaccine Adjuvants Segment by Application
2.4.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
2.4.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
2.5 Vaccine Adjuvants Consumption by Application
2.5.1 Global Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
2.5.2 Global Vaccine Adjuvants Value and Market Share by Type (2015-2020)
2.5.3 Global Vaccine Adjuvants Sale Price by Type (2015-2020)
3 Global Vaccine Adjuvants by Company
3.1 Global Vaccine Adjuvants Sales Market Share by Company
3.1.1 Global Vaccine Adjuvants Sales by Company (2018-2020)
3.1.2 Global Vaccine Adjuvants Sales Market Share by Company (2018-2020)
3.2 Global Vaccine Adjuvants Revenue Market Share by Company
3.2.1 Global Vaccine Adjuvants Revenue by Company (2018-2020)
3.2.2 Global Vaccine Adjuvants Revenue Market Share by Company (2018-2020)
3.3 Global Vaccine Adjuvants Sale Price by Company
3.4 Global Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Vaccine Adjuvants Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Vaccine Adjuvants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Vaccine Adjuvants by Regions
4.1 Vaccine Adjuvants by Regions
4.2 Americas Vaccine Adjuvants Consumption Growth
4.3 APAC Vaccine Adjuvants Consumption Growth
4.4 Europe Vaccine Adjuvants Consumption Growth
4.5 Middle East & Africa Vaccine Adjuvants Consumption Growth
5 Americas
5.1 Americas Vaccine Adjuvants Consumption by Countries
5.1.1 Americas Vaccine Adjuvants Consumption by Countries (2015-2020)
5.1.2 Americas Vaccine Adjuvants Value by Countries (2015-2020)
5.2 Americas Vaccine Adjuvants Consumption by Type
5.3 Americas Vaccine Adjuvants Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Vaccine Adjuvants Consumption by Regions
6.1.1 APAC Vaccine Adjuvants Consumption by Regions (2015-2020)
6.1.2 APAC Vaccine Adjuvants Value by Regions (2015-2020)
6.2 APAC Vaccine Adjuvants Consumption by Type
6.3 APAC Vaccine Adjuvants Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Vaccine Adjuvants by Countries
7.1.1 Europe Vaccine Adjuvants Consumption by Countries (2015-2020)
7.1.2 Europe Vaccine Adjuvants Value by Countries (2015-2020)
7.2 Europe Vaccine Adjuvants Consumption by Type
7.3 Europe Vaccine Adjuvants Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Vaccine Adjuvants by Countries
8.1.1 Middle East & Africa Vaccine Adjuvants Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Vaccine Adjuvants Value by Countries (2015-2020)
8.2 Middle East & Africa Vaccine Adjuvants Consumption by Type
8.3 Middle East & Africa Vaccine Adjuvants Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vaccine Adjuvants Distributors
10.3 Vaccine Adjuvants Customer
11 Global Vaccine Adjuvants Market Forecast
11.1 Global Vaccine Adjuvants Consumption Forecast (2021-2025)
11.2 Global Vaccine Adjuvants Forecast by Regions
11.2.1 Global Vaccine Adjuvants Forecast by Regions (2021-2025)
11.2.2 Global Vaccine Adjuvants Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Vaccine Adjuvants Forecast by Type
11.8 Global Vaccine Adjuvants Forecast by Application
12 Key Players Analysis
12.1 SEPPIC
12.1.1 Company Information
12.1.2 Vaccine Adjuvants Product Offered
12.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 SEPPIC Latest Developments
12.2 GSK
12.2.1 Company Information
12.2.2 Vaccine Adjuvants Product Offered
12.2.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 GSK Latest Developments
12.3 SDA BIO
12.3.1 Company Information
12.3.2 Vaccine Adjuvants Product Offered
12.3.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 SDA BIO Latest Developments
12.4 SPI Pharma
12.4.1 Company Information
12.4.2 Vaccine Adjuvants Product Offered
12.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 SPI Pharma Latest Developments
12.5 Phibro Animal Health Corporation
12.5.1 Company Information
12.5.2 Vaccine Adjuvants Product Offered
12.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Phibro Animal Health Corporation Latest Developments
12.6 Croda International Plc
12.6.1 Company Information
12.6.2 Vaccine Adjuvants Product Offered
12.6.3 Croda International Plc Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Croda International Plc Latest Developments
12.7 Zhuoyue
12.7.1 Company Information
12.7.2 Vaccine Adjuvants Product Offered
12.7.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Zhuoyue Latest Developments
12.8 Tj Kaiwei
12.8.1 Company Information
12.8.2 Vaccine Adjuvants Product Offered
12.8.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Tj Kaiwei Latest Developments
12.9 Aphios
12.9.1 Company Information
12.9.2 Vaccine Adjuvants Product Offered
12.9.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Aphios Latest Developments
12.10 Novavax
12.10.1 Company Information
12.10.2 Vaccine Adjuvants Product Offered
12.10.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Novavax Latest Developments
12.11 Avanti Polar Lipids
12.11.1 Company Information
12.11.2 Vaccine Adjuvants Product Offered
12.11.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Avanti Polar Lipids Latest Developments
12.12 Aphios
12.12.1 Company Information
12.12.2 Vaccine Adjuvants Product Offered
12.12.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Aphios Latest Developments
12.13 CSL Limited
12.13.1 Company Information
12.13.2 Vaccine Adjuvants Product Offered
12.13.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 CSL Limited Latest Developments
12.14 SPI Pharma
12.14.1 Company Information
12.14.2 Vaccine Adjuvants Product Offered
12.14.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 SPI Pharma Latest Developments
12.15 SEPPIC
12.15.1 Company Information
12.15.2 Vaccine Adjuvants Product Offered
12.15.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 SEPPIC Latest Developments
12.16 Novavax
12.16.1 Company Information
12.16.2 Vaccine Adjuvants Product Offered
12.16.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Novavax Latest Developments
12.17 Brenntag Biosector
12.17.1 Company Information
12.17.2 Vaccine Adjuvants Product Offered
12.17.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Brenntag Biosector Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Vaccine Adjuvants Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral
Table 5. Major Players of Subcutaneous
Table 6. Major Players of Intramuscular
Table 7. Major Players of Others
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
Table 10. Global Vaccine Adjuvants Revenue by Type (2015-2020) ($ million)
Table 11. Global Vaccine Adjuvants Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Vaccine Adjuvants Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Vaccine Adjuvants Consumption Market Share by Application (2015-2020)
Table 15. Global Vaccine Adjuvants Value by Application (2015-2020)
Table 16. Global Vaccine Adjuvants Value Market Share by Application (2015-2020)
Table 17. Global Vaccine Adjuvants Sale Price by Application (2015-2020)
Table 18. Global Vaccine Adjuvants Sales by Company (2017-2019) (Kg)
Table 19. Global Vaccine Adjuvants Sales Market Share by Company (2017-2019)
Table 20. Global Vaccine Adjuvants Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Vaccine Adjuvants Revenue Market Share by Company (2017-2019)
Table 22. Global Vaccine Adjuvants Sale Price by Company (2017-2019)
Table 23. Global Vaccine Adjuvants Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Vaccine Adjuvants Products Offered
Table 25. Vaccine Adjuvants Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Vaccine Adjuvants Consumption by Regions 2015-2020 (Kg)
Table 27. Global Vaccine Adjuvants Consumption Market Share by Regions 2015-2020
Table 28. Global Vaccine Adjuvants Value by Regions 2015-2020 ($ Millions)
Table 29. Global Vaccine Adjuvants Value Market Share by Regions 2015-2020
Table 30. Americas Vaccine Adjuvants Consumption by Countries (2015-2020) (Kg)
Table 31. Americas Vaccine Adjuvants Consumption Market Share by Countries (2015-2020)
Table 32. Americas Vaccine Adjuvants Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Vaccine Adjuvants Value Market Share by Countries (2015-2020)
Table 34. Americas Vaccine Adjuvants Consumption by Type (2015-2020) (Kg)
Table 35. Americas Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
Table 36. Americas Vaccine Adjuvants Consumption by Application (2015-2020) (Kg)
Table 37. Americas Vaccine Adjuvants Consumption Market Share by Application (2015-2020)
Table 38. APAC Vaccine Adjuvants Consumption by Countries (2015-2020) (Kg)
Table 39. APAC Vaccine Adjuvants Consumption Market Share by Countries (2015-2020)
Table 40. APAC Vaccine Adjuvants Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Vaccine Adjuvants Value Market Share by Regions (2015-2020)
Table 42. APAC Vaccine Adjuvants Consumption by Type (2015-2020) (Kg)
Table 43. APAC Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
Table 44. APAC Vaccine Adjuvants Consumption by Application (2015-2020) (Kg)
Table 45. APAC Vaccine Adjuvants Consumption Market Share by Application (2015-2020)
Table 46. Europe Vaccine Adjuvants Consumption by Countries (2015-2020) (Kg)
Table 47. Europe Vaccine Adjuvants Consumption Market Share by Countries (2015-2020)
Table 48. Europe Vaccine Adjuvants Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Vaccine Adjuvants Value Market Share by Countries (2015-2020)
Table 50. Europe Vaccine Adjuvants Consumption by Type (2015-2020) (Kg)
Table 51. Europe Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
Table 52. Europe Vaccine Adjuvants Consumption by Application (2015-2020) (Kg)
Table 53. Europe Vaccine Adjuvants Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Vaccine Adjuvants Consumption by Countries (2015-2020) (Kg)
Table 55. Middle East & Africa Vaccine Adjuvants Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Vaccine Adjuvants Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Vaccine Adjuvants Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Vaccine Adjuvants Consumption by Type (2015-2020) (Kg)
Table 59. Middle East & Africa Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Vaccine Adjuvants Consumption by Application (2015-2020) (Kg)
Table 61. Middle East & Africa Vaccine Adjuvants Consumption Market Share by Application (2015-2020)
Table 62. Vaccine Adjuvants Distributors List
Table 63. Vaccine Adjuvants Customer List
Table 64. Global Vaccine Adjuvants Consumption Forecast by Countries (2021-2025) (Kg)
Table 65. Global Vaccine Adjuvants Consumption Market Forecast by Regions
Table 66. Global Vaccine Adjuvants Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Vaccine Adjuvants Value Market Share Forecast by Regions
Table 68. Global Vaccine Adjuvants Consumption Forecast by Type (2021-2025) (Kg)
Table 69. Global Vaccine Adjuvants Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Vaccine Adjuvants Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Vaccine Adjuvants Value Market Share Forecast by Type (2021-2025)
Table 72. Global Vaccine Adjuvants Consumption Forecast by Application (2021-2025) (Kg)
Table 73. Global Vaccine Adjuvants Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Vaccine Adjuvants Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Vaccine Adjuvants Value Market Share Forecast by Application (2021-2025)
Table 76. SEPPIC Product Offered
Table 77. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 78. SEPPIC Main Business
Table 79. SEPPIC Latest Developments
Table 80. SEPPIC Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Product Offered
Table 82. GSK Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. GSK Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 86. SDA BIO Product Offered
Table 87. SDA BIO Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 88. SDA BIO Main Business
Table 89. SDA BIO Latest Developments
Table 90. SDA BIO Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 91. SPI Pharma Product Offered
Table 92. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 93. SPI Pharma Main Business
Table 94. SPI Pharma Latest Developments
Table 95. SPI Pharma Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 96. Phibro Animal Health Corporation Product Offered
Table 97. Phibro Animal Health Corporation Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 98. Phibro Animal Health Corporation Main Business
Table 99. Phibro Animal Health Corporation Latest Developments
Table 100. Phibro Animal Health Corporation Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 101. Croda International Plc Product Offered
Table 102. Croda International Plc Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 103. Croda International Plc Main Business
Table 104. Croda International Plc Latest Developments
Table 105. Croda International Plc Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 106. Zhuoyue Product Offered
Table 107. Zhuoyue Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 108. Zhuoyue Main Business
Table 109. Zhuoyue Latest Developments
Table 110. Zhuoyue Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. Tj Kaiwei Product Offered
Table 112. Tj Kaiwei Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 113. Tj Kaiwei Main Business
Table 114. Tj Kaiwei Latest Developments
Table 115. Tj Kaiwei Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 116. Aphios Product Offered
Table 117. Aphios Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 118. Aphios Main Business
Table 119. Aphios Latest Developments
Table 120. Aphios Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 121. Novavax Product Offered
Table 122. Novavax Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 123. Novavax Main Business
Table 124. Novavax Latest Developments
Table 125. Novavax Basic Information, Company Total Revenue (in $ million), Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 126. Avanti Polar Lipids Product Offered
Table 127. Avanti Polar Lipids Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 128. Avanti Polar Lipids Main Business
Table 129. Avanti Polar Lipids Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Avanti Polar Lipids Latest Developments
Table 131. Aphios Product Offered
Table 132. Aphios Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 133. Aphios Main Business
Table 134. Aphios Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Aphios Latest Developments
Table 136. CSL Limited Product Offered
Table 137. CSL Limited Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 138. CSL Limited Main Business
Table 139. CSL Limited Latest Developments
Table 140. CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. SPI Pharma Product Offered
Table 142. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 143. SPI Pharma Main Business
Table 144. SPI Pharma Latest Developments
Table 145. SPI Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. SEPPIC Product Offered
Table 147. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 148. SEPPIC Main Business
Table 149. SEPPIC Latest Developments
Table 150. SEPPIC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. Novavax Product Offered
Table 152. Novavax Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 153. Novavax Main Business
Table 154. Novavax Latest Developments
Table 155. Novavax Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 156. Brenntag Biosector Product Offered
Table 157. Brenntag Biosector Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 158. Brenntag Biosector Main Business
Table 159. Brenntag Biosector Latest Developments
Table 160. Brenntag Biosector Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Vaccine Adjuvants
Figure 2. Vaccine Adjuvants Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Vaccine Adjuvants Consumption Growth Rate 2015-2025 (Kg)
Figure 5. Global Vaccine Adjuvants Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral
Figure 7. Product Picture of Subcutaneous
Figure 8. Product Picture of Intramuscular
Figure 9. Product Picture of Others
Figure 10. Global Vaccine Adjuvants Consumption Market Share by Type (2015-2020)
Figure 11. Global Vaccine Adjuvants Value Market Share by Type (2015-2020)
Figure 12. Vaccine Adjuvants Consumed in Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Figure 13. Global Vaccine Adjuvants Market: Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) (2015-2020) (Kg)
Figure 14. Global Vaccine Adjuvants Market: Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) (2015-2020) ($ Millions)
Figure 15. Vaccine Adjuvants Consumed in Human Vaccine Adjuvants (Research Applications, Commercial Applications)
Figure 16. Global Vaccine Adjuvants Market: Human Vaccine Adjuvants (Research Applications, Commercial Applications) (2015-2020) (Kg)
Figure 17. Global Vaccine Adjuvants Market: Human Vaccine Adjuvants (Research Applications, Commercial Applications) (2015-2020) ($ Millions)
Figure 18. Global Vaccine Adjuvants Consumption Market Share by Application (2015-2020)
Figure 19. Global Vaccine Adjuvants Value Market Share by Application (2015-2020)
Figure 20. Global Vaccine Adjuvants Sales Market Share by Company in 2017
Figure 21. Global Vaccine Adjuvants Sales Market Share by Company in 2019
Figure 22. Global Vaccine Adjuvants Revenue Market Share by Company in 2017
Figure 23. Global Vaccine Adjuvants Revenue Market Share by Company in 2019
Figure 24. Global Vaccine Adjuvants Sale Price by Company in 2019
Figure 25. Global Vaccine Adjuvants Consumption Market Share by Regions 2015-2020
Figure 26. Global Vaccine Adjuvants Value Market Share by Regions 2015-2020
Figure 27. Americas Vaccine Adjuvants Consumption 2015-2020 (Kg)
Figure 28. Americas Vaccine Adjuvants Value 2015-2020 ($ Millions)
Figure 29. APAC Vaccine Adjuvants Consumption 2015-2020 (Kg)
Figure 30. APAC Vaccine Adjuvants Value 2015-2020 ($ Millions)
Figure 31. Europe Vaccine Adjuvants Consumption 2015-2020 (Kg)
Figure 32. Europe Vaccine Adjuvants Value 2015-2020 ($ Millions)
Figure 33. Middle East & Africa Vaccine Adjuvants Consumption 2015-2020 (Kg)
Figure 34. Middle East & Africa Vaccine Adjuvants Value 2015-2020 ($ Millions)
Figure 35. Americas Vaccine Adjuvants Consumption Market Share by Countries in 2019
Figure 36. Americas Vaccine Adjuvants Value Market Share by Countries in 2019
Figure 37. Americas Vaccine Adjuvants Consumption Market Share by Type in 2019
Figure 38. Americas Vaccine Adjuvants Consumption Market Share by Application in 2019
Figure 39. United States Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 40. United States Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 41. Canada Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 42. Canada Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 43. Mexico Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 44. Mexico Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 45. APAC Vaccine Adjuvants Consumption Market Share by Countries in 2019
Figure 46. APAC Vaccine Adjuvants Value Market Share by Regions in 2019
Figure 47. APAC Vaccine Adjuvants Consumption Market Share by Type in 2019
Figure 48. APAC Vaccine Adjuvants Consumption Market Share by Application in 2019
Figure 49. China Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 50. China Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 51. Japan Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 52. Japan Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 53. Korea Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 54. Korea Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 55. Southeast Asia Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 56. Southeast Asia Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 57. India Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 58. India Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 59. Australia Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 60. Australia Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 61. Europe Vaccine Adjuvants Consumption Market Share by Countries in 2019
Figure 62. Europe Vaccine Adjuvants Value Market Share by Countries in 2019
Figure 63. Europe Vaccine Adjuvants Consumption Market Share by Type in 2019
Figure 64. Europe Vaccine Adjuvants Consumption Market Share by Application in 2019
Figure 65. Germany Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 66. Germany Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 67. France Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 68. France Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 69. UK Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 70. UK Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 71. Italy Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 72. Italy Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 73. Russia Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 74. Russia Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 75. Middle East & Africa Vaccine Adjuvants Consumption Market Share by Countries in 2019
Figure 76. Middle East & Africa Vaccine Adjuvants Value Market Share by Countries in 2019
Figure 77. Middle East & Africa Vaccine Adjuvants Consumption Market Share by Type in 2019
Figure 78. Middle East & Africa Vaccine Adjuvants Consumption Market Share by Application in 2019
Figure 79. Egypt Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 80. Egypt Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 81. South Africa Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 82. South Africa Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 83. Israel Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 84. Israel Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 85. Turkey Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 86. Turkey Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 87. GCC Countries Vaccine Adjuvants Consumption Growth 2015-2020 (Kg)
Figure 88. GCC Countries Vaccine Adjuvants Value Growth 2015-2020 ($ Millions)
Figure 89. Global Vaccine Adjuvants Consumption Growth Rate Forecast (2021-2025) (Kg)
Figure 90. Global Vaccine Adjuvants Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 91. Americas Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 92. Americas Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 93. APAC Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 94. APAC Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 95. Europe Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 96. Europe Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 97. Middle East & Africa Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 98. Middle East & Africa Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 99. United States Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 100. United States Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 101. Canada Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 102. Canada Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 103. Mexico Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 104. Mexico Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 105. Brazil Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 106. Brazil Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 107. China Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 108. China Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 109. Japan Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 110. Japan Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 111. Korea Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 112. Korea Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 113. Southeast Asia Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 114. Southeast Asia Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 115. India Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 116. India Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 117. Australia Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 118. Australia Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 119. Germany Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 120. Germany Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 121. France Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 122. France Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 123. UK Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 124. UK Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 125. Italy Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 126. Italy Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 127. Russia Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 128. Russia Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 129. Spain Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 130. Spain Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 131. Egypt Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 132. Egypt Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 133. South Africa Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 134. South Africa Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 135. Israel Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 136. Israel Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 137. Turkey Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 138. Turkey Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 139. GCC Countries Vaccine Adjuvants Consumption 2021-2025 (Kg)
Figure 140. GCC Countries Vaccine Adjuvants Value 2021-2025 ($ Millions)
Figure 141. SEPPIC Vaccine Adjuvants Market Share (2018-2020)
Figure 142. GSK Vaccine Adjuvants Market Share (2018-2020)
Figure 143. SDA BIO Vaccine Adjuvants Market Share (2018-2020)
Figure 144. SPI Pharma Vaccine Adjuvants Market Share (2018-2020)
Figure 145. Phibro Animal Health Corporation Vaccine Adjuvants Market Share (2018-2020)
Figure 146. Croda International Plc Vaccine Adjuvants Market Share (2018-2020)
Figure 147. Zhuoyue Vaccine Adjuvants Market Share (2018-2020)
Figure 148. Tj Kaiwei Vaccine Adjuvants Market Share (2018-2020)
Figure 149. Aphios Vaccine Adjuvants Market Share (2018-2020)
Figure 150. Novavax Vaccine Adjuvants Market Share (2018-2020)
Figure 151. Avanti Polar Lipids Vaccine Adjuvants Market Share (2018-2020)
Figure 152. Aphios Vaccine Adjuvants Market Share (2018-2020)
Figure 153. CSL Limited Vaccine Adjuvants Market Share (2018-2020)
Figure 154. SPI Pharma Vaccine Adjuvants Market Share (2018-2020)
Figure 155. SEPPIC Vaccine Adjuvants Market Share (2018-2020)
Figure 156. Novavax Vaccine Adjuvants Market Share (2018-2020)
Figure 157. Brenntag Biosector Vaccine Adjuvants Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets